Literature DB >> 27575030

Nervous System Expression of PPARγ and Mutant PPARγ Has Profound Effects on Metabolic Regulation and Brain Development.

Madeliene Stump1, Deng-Fu Guo1, Ko-Ting Lu1, Masashi Mukohda1, Martin D Cassell1, Andrew W Norris1, Kamal Rahmouni1, Curt D Sigmund1.   

Abstract

Peroxisome proliferator activated receptor (PPARγ) is a nuclear receptor transcription factor that regulates adipogenesis and energy homeostasis. Recent studies suggest PPARγ may mediate some of its metabolic effects through actions in the brain. We used a Cre-recombinase-dependent (using NestinCre) conditionally activatable transgene expressing either wild-type (WT) or dominant-negative (P467L) PPARγ to examine mechanisms by which PPARγ in the nervous system controls energy balance. Inducible expression of PPARγ was evident throughout the brain. Expression of 2 PPARγ target genes, aP2 and CD36, was induced by WT but not P467L PPARγ in the brain. Surprisingly, NesCre/PPARγ-WT mice exhibited severe microcephaly and brain malformation, suggesting that PPARγ can modulate brain development. On the contrary, NesCre/PPARγ-P467L mice exhibited blunted weight gain to high-fat diet, which correlated with a decrease in lean mass and tissue masses, accompanied by elevated plasma GH, and depressed plasma IGF-1, indicative of GH resistance. There was no expression of the transgene in the pancreas but both fasting plasma glucose, and fed and fasted plasma insulin levels were markedly decreased. NesCre/PPARγ-P467L mice fed either control diet or high-fat diet displayed impaired glucose tolerance yet exhibited increased sensitivity to exogenous insulin and increased insulin receptor signaling in white adipose tissue, liver, and skeletal muscle. These observations support the concept that alterations in PPARγ-driven mechanisms in the nervous system play a role in the regulation of growth and glucose metabolic homeostasis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27575030      PMCID: PMC5086539          DOI: 10.1210/en.2016-1524

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

1.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight.

Authors:  T Schöndorf; T Forst; C Hohberg; S Pahler; C Link; W Roth; A Pfützner; G Lübben; C Link; A Pfützner
Journal:  Diabetes Obes Metab       Date:  2007-01       Impact factor: 6.577

3.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

Review 4.  Central insulin and leptin-mediated autonomic control of glucose homeostasis.

Authors:  Joseph S Marino; Yong Xu; Jennifer W Hill
Journal:  Trends Endocrinol Metab       Date:  2011-04-12       Impact factor: 12.015

5.  A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

Authors:  Y Zhou; B C Xu; H G Maheshwari; L He; M Reed; M Lozykowski; S Okada; L Cataldo; K Coschigamo; T E Wagner; G Baumann; J J Kopchick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

7.  Nestin-Cre mice are affected by hypopituitarism, which is not due to significant activity of the transgene in the pituitary gland.

Authors:  Christophe Galichet; Robin Lovell-Badge; Karine Rizzoti
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

8.  Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Authors:  Philip D Home; Stuart J Pocock; Henning Beck-Nielsen; Paula S Curtis; Ramon Gomis; Markolf Hanefeld; Nigel P Jones; Michel Komajda; John J V McMurray
Journal:  Lancet       Date:  2009-06-06       Impact factor: 79.321

9.  Effect of intensive insulin treatment on linear growth in the young diabetic patient.

Authors:  M C Rudolf; R S Sherwin; R Markowitz; S E Bates; M Genel; J Hochstadt; W V Tamborlane
Journal:  J Pediatr       Date:  1982-09       Impact factor: 4.406

10.  Height at diagnosis of diabetes in children: a study in identical twins.

Authors:  P J Hoskins; R D Leslie; D A Pyke
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26
View more
  8 in total

1.  Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.

Authors:  Masashi Mukohda; Ko-Ting Lu; Deng-Fu Guo; Jing Wu; Henry L Keen; Xuebo Liu; Pimonrat Ketsawatsomkron; Madeliene Stump; Kamal Rahmouni; Frederick W Quelle; Curt D Sigmund
Journal:  Hypertension       Date:  2017-05-15       Impact factor: 10.190

2.  RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity.

Authors:  Masashi Mukohda; Shi Fang; Jing Wu; Larry N Agbor; Anand R Nair; Stella-Rita C Ibeawuchi; Chunyan Hu; Xuebo Liu; Ko-Ting Lu; Deng-Fu Guo; Deborah R Davis; Henry L Keen; Frederick W Quelle; Curt D Sigmund
Journal:  J Clin Invest       Date:  2019-03-21       Impact factor: 14.808

3.  Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism.

Authors:  Larry N Agbor; Stella-Rita C Ibeawuchi; Chunyan Hu; Jing Wu; Deborah R Davis; Henry L Keen; Frederick W Quelle; Curt D Sigmund
Journal:  JCI Insight       Date:  2016-11-17

Review 4.  Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.

Authors:  Shreekrishna Lamichane; Babita Dahal Lamichane; Sang-Mo Kwon
Journal:  Int J Mol Sci       Date:  2018-03-22       Impact factor: 5.923

Review 5.  PPARs and Energy Metabolism Adaptation during Neurogenesis and Neuronal Maturation.

Authors:  Michele D'Angelo; Andrea Antonosante; Vanessa Castelli; Mariano Catanesi; NandhaKumar Moorthy; Dalila Iannotta; Annamaria Cimini; Elisabetta Benedetti
Journal:  Int J Mol Sci       Date:  2018-06-26       Impact factor: 5.923

Review 6.  Behavioral Feeding Circuit: Dietary Fat-Induced Effects of Inflammatory Mediators in the Hypothalamus.

Authors:  Kinning Poon
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-26       Impact factor: 5.555

Review 7.  Central Neurocircuits Regulating Food Intake in Response to Gut Inputs-Preclinical Evidence.

Authors:  Kirsteen N Browning; Kaitlin E Carson
Journal:  Nutrients       Date:  2021-03-11       Impact factor: 5.717

Review 8.  Role of the Peroxisome Proliferator Activated Receptors in Hypertension.

Authors:  Shi Fang; M Christine Livergood; Pablo Nakagawa; Jing Wu; Curt D Sigmund
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 23.213

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.